The role of TLRs in neuroinflammation
Author: Shehnaz Ahmad
The role of TLRs in neuroinflammation
Neurodegenerative diseases affect millions of people all over the world; for example over 5 million people in the United States alone have been diagnosed with Alzheimer’s disease (AD). Although all underlying causes are not fully understood, neuroinflammation and immune responses play a big part in the onset of neurodegeneration. Evidence shows that microglia, astrocytes, oligodendrocytes and neurons are all capable of initiating immune responses in the brain that could contribute to AD as they produce and signal via neuroinflammatory components such as cytokines, interleukins, chemokines, leukocytes and endothelial adhesion molecules. In that context much research focuses on decyphering the role played by reactive oxygen species, toll like receptor (TLR) and NFkappaB (NF-kB) mediated signaling pathway.
Is neuroinflammation a cause of or a consequence of neurodegeneration and is it protective or destructive? Acute neuroinflammation is required for the removal of amyloid beta (Aβ) plaques by microglia. On the other hand on-going neuroinflammation results in glial dysfunction and neuronal compromise. Therefore, the time period and intensity of the inflammatory response is critical in regard to answering whether the response is protective or destructive.
Injury to the brain leads to the activation of repair pathways such as the recovery of the neuronal network, enhancing plasticity and providing alternative methods of performing tasks that were abolished due to the loss of brain tissue. Neuroinflammation is the response by glial cells (e.g. microglia and astrocytes) to infection or injury as part of the innate immune system. Activated glial cells produce pro-inflammatory cytokines, enzymes and adhesion molecules - a response aided by TLRs.
Ischemic mice negative for tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6), showed a larger amount of necrotic tissue when their inflammatory response was activated, indicating a protective role of the inflammation mediator products TNFα and IL-6. In addition to that, other cytokines such as the IL-1 family play a detrimental role in inflammation; e.g. the deletion of IL-1α and IL-1β in mice reduced ischemic brain damage (Boutin et al,. 2001). IL-1 is expressed after insult and in an NF-kB dependent manner. It therefore appears that timing as well as specific cytokine expression, which is often regulated by TLR signaling, is crucial in determining whether inflammation helps or hinders repair.
During aging secretion of pro-inflammatory cytokines is increased, whereas levels of anti-inflammatory cytokines decrease. Similarly TLR signaling is also altered during aging. This suggests that TLRs and inflammation are important factors in the onset of all kinds of age related diseases.
TLRs play a key role in the development and regulation of inflammation, neurodegeneration and brain trauma. They are crucial components in activating the innate immune response against invading pathogens in addition to playing a key role in neuronal degeneration, neurogenesis and neurite outgrowth. All these aspects taken together suggest an important role in maintaining neuronal plasticity. In total eleven human and thirteen mouse TLRs have been identified, all belonging to the pattern recognition receptor (PRR) family, along with other receptors such as CD206 , and NALP (a Nod-like receptor). TLRs are expressed on a large variety of immune-related cells, including microglia, astrocytes, oligodendrocytes and neurons in the brain. Their expression patterns are dependent on the presence of pathogens, cytokines and environmental stresses.
TLRs are either expressed on the cell surface (TLR1, 2, 4, 5, and 6) or in endosomal vesicles (TLR3, 7, 8, and 9). Characteristic for all TLRs is a leucine-rich extracellular domain, which is involved in recognizing pathogen associated molecular patterns (PAMPs). Also conserved is a cytoplasmic Toll-IL-1 receptor (TIR) domain, which initiates downstream signaling via mediating interactions between TLRs and TIR-adapter proteins such as myeloid differentiation factor 88 (MyD88), TIR-adapter proteins (TIRAP), TIR-domain-containing adapter-inducing interferon-β (TRIF) and (TRIF-related adaptor molecule) TRAM. These interactions result in the upregulation and expression of inflammation regulating transcription factors such as NF-kB.
TLR4 is highly conserved from Drosophila melanogaster to humans. The active form of TLR4 is able to activate the NF-kB pathway thereby leading to the expression of NF-kB-dependent inflammatory genes and CD80 which are crucial in a T cell reponse.These are all necessary for the activation of naïve T lymphocytes, key players in an innate immune response (Medzhitov et al., 1997). Repeated stress exposure upregulates TLR4 expression suggesting a key role of TLR4 in stress-induced NF-κB activation, iNOS and COX-2 upregulation, and cellular oxidative/nitrosative damage responses. TLR4 signaling also affects IL-1β, IL-10 and IL-7 levels.
TLRs form either homo- or heterodimers and are categorized into three main groups (Table 1) according to the specific PAMP motif they recognize. These classes are:
Table 1: TLR overview
After PAMP recognition, TLR signaling is mediated in either a MyD88 dependent or MyD88 independent/Trif dependent manner. MyD88 is an adapter protein that mainly interacts with TIRAP/ MyD88-adapter-like (Mal) and TRAM proteins and plays a crucial role in enabling the recruitment of the IL-1R associated kinases ( IRAK ) -1, 2, 3, 4. TIRAP /Mal and TRAM are also required for the activation of TRIF dependent signaling. All TLRs signal via the MyD88-dependent pathway, except for TLR3 which signals exclusively via TRIF.
Key steps in both MyD88 and TRIF mediated TLR signaling have been outlined below using TLR4 as an example. The outcome of both pathways is the activation of IRF3, NF-kB and AB-1, which regulate the expression of pro-inflammatory cytokines and type 1 IFN.
Microglia are macrophage-like cells present in the central nervous system (CNS) that mediate neuronal immune interactions. Activated microglia appear to have mainly a neuroprotective role in acute injury. Stress conditions, such as hypoxia, result in increased TLR signaling in microglia. Apart from TLR10, all TLRs are expressed in microglia (Table 2). TLR4 and TLR2 for example have been implicated in sensitizing microglial apoptosis suggesting a role in preventing excessive inflammation. Microglia produce pro-inflammatory cytokines, enzymes and adhesion molecules, which initiate leukocyte migration through the blood brain barrier and promote effector functions in these infiltrating cells.
Table 2: TLRs in microglial
Human astrocytes express TLR1-7, 9 and 10 (see table 3). Drugs such as statins increase astrocyte TLR4-mediated cytokine production and are linked to neuropathies. Cytokines and TLR agonists in return also increase the expression of chemokine ligands such as CCL2, CCL3, and CCL5, which go on to attract immune cells to the site of inflammation.
IL-1α, IL-1β, IL-6, TNFα, GM-CSF, LTB, TGF-B3
Table 3: TLRs in astrocytes
Oligodendrocytes are a type of neuroglia that support and insulate axons in the CNS by creating a myelin sheath. Injury to these cells can result in demyelination, and subsequently development of diseases such as Multiple Sclerosis. Little evidence is available on the role of TLRs in oligodendrocytes, apart from the fact that TLR2,3 and 4 are expressed in these cells.
Oligodendrocytes, in which TLR signalling has been activated by treatment with the TLR2 agonist Zymosan, have been shown to play a role in the repair of damage to the CNS and inflammation-mediated remyelination (Setzu et al., 2006). This strongly suggests a neuroprotective role of TLR2. However, contradicting results imply that Zymosan-mediated TLR2 activation results in complete oligodendrocyte loss and demyelination of intact myelin axons around lesions (Schonberg et al,. 2007). Further research is needed to fully understand the role of TLR2.
There is increasing evidence for the importance of aberrant TLR neuronal expression in the development of pathological conditions. A distinct difference is seen in TLR activation in differentiated neurons versus neuronal progenitor cells, although both cell types express TLR2 and TLR4. TLR2 is involved in hippocampal neurogenesis, while TLR4 reduces proliferation and neuronal differentiation. Both TLRs regulate cell fate via MyD88 and NF-kB pathways, however, this is specific to progenitor cells, the mediators of differentiated cells are unknown.
Table 4: TLRs in Neurons
This minireview has emphasized the importance that TLRs play in the mediation and regulation of neuroinflammation. Although a lot of progress has been made in researching neuroinflammation, especially in a disease context, many questions remain open. These include why different neuronal cell types show different levels of damage vulnerability and identifying the molecular mechanisms underlying inflammatory neurodegeneration. Additionally it is essential to understand the control of recovery and neuronal plasticity after inflammation induced brain damage.
Boutin, H et al. (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage
J Neurosci 21(17)
Medzhitov, R et al.(1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
Okun, E et al. (2009) Toll-like Receptors in Neurodegeneration
Brain Res Rev 59(2): 278-292
Schonberg, DL et al. (2007) Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation
J. Neuropathol. Exp. Neurol 66; 1124-1135
Setzu, A et al. (2006) Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells
Glia, 54; 297-303
Payment methods we support: